Pharmacological profile of U-37883A, a channel blocker of smooth muscle-type ATP-sensitive K+ channels

Cardiovascular Drug Reviews

Volumn 24, Issue 1, 2006, Pages 25-32

  Teramoto, Noriyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ATP sensitive K+ channels; Channel blocker; Inwardly rectified K+ channels; Tissue selectivity; U 37883A; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLIMEPIRIDE; ION CHANNEL; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; NATEGLINIDE; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; ADAMANTANE; DIURETIC AGENT; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT;

ANTIHYPERTENSIVE ACTIVITY; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; KIDNEY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; URETHRA; VASCULAR SMOOTH MUSCLE; ANIMAL; CHEMISTRY; DRUG EFFECT;

ADAMANTANE; ANIMALS; DIURETICS; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 34247849292     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2006.00025.x     Document Type: Review

References (27)

1. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphospate-sensitive potassium channels. Endocrine Rev 1999 20 : 101 135.
2. Akiyoshi M, Kakei M, Nakazaki M, et al. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic-cells. Am J Physiol 1995 268 : E185 E193.
3. Ashcroft FM. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988 11 : 97 118.
4. Beech DJ, Zhang H, Nakao K, et al. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 1993 110 : 573 582.
5. Chachin M, Yamada M, Fujita A, et al. N ateglinide, a D-phenylalanine derivative lacking either a sulfonyl-urea or benzamido moiety, specifically inhibits pancreatic beta-cell-type KATP channels. J Pharmacol Exp Ther 2003 304 : 1025 1032.
6. Cipkus-Dubray L, Swirtz M, Khan S, et al. U -37883A: A structurally novel antagonist of the vascular KATP openers. FASEB J 1992 6 : A1777.
7. Cui Y, Giblin JP, Clapp LH, et al. A mechanism for ATP-sensitive potassium channel diversity: Functional coassembly of two pore-forming subunits. Proc Natl Acad Sci USA 2001 98 : 729 734.
8. Guillemare E, Honore E, De Weille J, et al. F unctional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: Comparison with rat insulinoma cells. Mol Pharmacol 1994 46 : 139 145.
9. Humphrey SJ, Smith MP, Cimini MG, et al. C ardiovascular effects of the KATP channel blocker U-37883A and structurally related morpholinoguanidines. Meth Find Exp Clin Pharmacol 1996 18 : 247 260.
10. Isomoto S, Kondo C, Yamada M, et al. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem 1996 271 : 24321 24324.
11. Kovalev H, Quayle JM, Kamishima T, et al. M olecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A. Br J Pharmacol 2004 141 : 867 873.
12. Lee K, Ozanne SE, Hales CN, et al. M g2+ -dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells. Br J Pharmacol 1994 111 : 632 640.
13. Lin YJ, Chen X, Freedman JE. U -37883A potently inhibits dopamine-modulated K+ channels on rat striatal neurons. Eur J Pharmacol 1998 352 : 335 341.
14. Ludens JH, Clark MA, Smith MP, et al. R enal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats. J Cardiovasc Pharmacol 1995 25 : 404 409.
15. Meisheri KD, Fosset M, Humphrey SJ, et al. R eceptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/([a-z])atriuretic properties. Mol Pharmacol 1994 47 : 155 163.
16. Meisheri KD, Humphrey SJ, Khan SA, et al. 4-Morpholinecarboximidine-N-1- adamantyl-N′-cyclohexyl-hydrochloride (U-37883A): Pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers. J Pharmacol Exp Ther 1993 266 : 655 665.
17. Noma A. A TP-regulated K+ channels in cardiac muscle. Nature 1983 305 : 147 148.
18. Seino S. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/([a-z])eceptor assemblies. Ann Rev Physiol 1999 61 : 337 362.
19. Surah-Narwal S, Xu SZ, McHugh D, et al. B lock of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883A. Br J Pharmacol 1999 128 : 667 672.
20. Teramoto N. P hysiological roles of ATP-sensitive K+ channels in smooth muscle. J Physiol 2006 572 : 617 624.
21. Teramoto N, Aishima M, Zhu HL, et al. E ffects of U-37883A on intracellular Ca2+-activated large conductance K+ channels in pig proximal urethral myocytes. Eur J Pharmacol 2004 506 : 1 7.
22. Tomoda T, Yunoki T, Naito S, et al. M ultiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra. Eur J Pharmacol 2005 524 : 1 10.
23. Wang T, Wang, WH, Klein-Robbenhaar, G, et al. E ffects of a novel KATP channel blocker on renal tubule function and K+ channel activity. J Pharmacol Exp Ther 1995 273 : 1382 1389.
24. Wellman GC, Barrett-Jolley R, Koppel H, et al. I nhibition of vascular KATP channels by U-37883A: A comparison with cardiac and skeletal muscle. Br J Pharmacol 1999 128 : 909 916.
25. Wilson C. I in vitro. J Auton Pharmacol 1989 9 : 71 78.
26. Yamada M, Isomoto S, Matsumoto S, et al. S ulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J Physiol 1997 499 : 715 720.
27. Zhang H-L, Bolton TB. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol 1996 118 : 105 114.